These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29154770)

  • 1. Density and Shape Factor Terms in Stokes' Equation for Aerodynamic Behavior of Aerosols.
    Hickey AJ; Edwards DA
    J Pharm Sci; 2018 Mar; 107(3):794-796. PubMed ID: 29154770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fundamental effects of particle morphology on lung delivery: predictions of Stokes' law and the particular relevance to dry powder inhaler formulation and development.
    Crowder TM; Rosati JA; Schroeter JD; Hickey AJ; Martonen TB
    Pharm Res; 2002 Mar; 19(3):239-45. PubMed ID: 11934228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of the Performance of Efficient Data Analysis Versus Fine Particle Dose as Metrics for the Quality Control of Aerodynamic Particle Size Distributions of Orally Inhaled Pharmaceuticals.
    Tougas TP; Goodey AP; Hardwell G; Mitchell J; Lyapustina S
    AAPS PharmSciTech; 2017 Feb; 18(2):451-461. PubMed ID: 27068528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle sizing of pharmaceutical aerosols via direct imaging of particle settling velocities.
    Fishler R; Verhoeven F; de Kruijf W; Sznitman J
    Eur J Pharm Sci; 2018 Feb; 113():152-158. PubMed ID: 28821437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of nonideal cascade impactor stage collection efficiency curves on the interpretation of the size of inhaler-generated aerosols.
    Roberts DL; Mitchell JP
    AAPS PharmSciTech; 2013 Jun; 14(2):497-510. PubMed ID: 23508617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
    AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle Size Measurements from Orally Inhaled and Nasal Drug Products.
    Mitchell JP
    J Aerosol Med Pulm Drug Deliv; 2021 Dec; 34(6):325-345. PubMed ID: 34860563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallization of progesterone for pulmonary drug delivery.
    Ragab D; Rohani S; Samaha MW; El-Khawas FM; El-Maradny HA
    J Pharm Sci; 2010 Mar; 99(3):1123-37. PubMed ID: 19691108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the deposition of inhaled porous drug particles.
    Musante CJ; Schroeter JD; Rosati JA; Crowder TM; Hickey AJ; Martonen TB
    J Pharm Sci; 2002 Jul; 91(7):1590-600. PubMed ID: 12115821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new real-time method for determining particles' sphericity and density: application to secondary organic aerosol formed by ozonolysis of alpha-pinene.
    Zelenyuk A; Yang J; Song C; Zaveri RA; Imre D
    Environ Sci Technol; 2008 Nov; 42(21):8033-8. PubMed ID: 19031898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Geometric and Aerodynamic Particle Size Distributions in the Formulation of Solution and Suspension Metered-Dose Inhalers.
    Yoshida H; Usui A; Abe Y; Goda Y; Izutsu KI
    AAPS PharmSciTech; 2020 May; 21(5):158. PubMed ID: 32458106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calibration of the modified Electrical Low-Pressure Impactor (ELPI) for use with pressurized pharmaceutical aerosols.
    Kotian R; Peart J; Bryner J; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):55-65. PubMed ID: 18954291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel dry powder inhalation system based on dispersion of lyophilisates.
    Claus S; Schoenbrodt T; Weiler C; Friess W
    Eur J Pharm Sci; 2011 May; 43(1-2):32-40. PubMed ID: 21440061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling and Understanding Combination pMDI Formulations with Both Dissolved and Suspended Drugs.
    Stein SW; Sheth P; Younis US; Mogalian E; Myrdal PB
    Mol Pharm; 2015 Sep; 12(9):3455-67. PubMed ID: 26258647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W; Ticehurst M; Nokhodchi A
    Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Particle Size Distributions.
    Finlay WH; Darquenne C
    J Aerosol Med Pulm Drug Deliv; 2020 Aug; 33(4):178-180. PubMed ID: 32598205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro/in vivo comparisons in pulmonary drug delivery.
    Newman SP; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):77-84. PubMed ID: 18518834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Pulmonary Cell Culture in Pharmaceutical Inhalation Aerosol Delivery: 2-D, 3-D, and In Situ Bioimpactor Models.
    Acosta MF; Muralidharan P; Meenach SA; Hayes D; M-Black S; Mansour HM
    Curr Pharm Des; 2016; 22(17):2522-31. PubMed ID: 26831643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.